AI Summary
5 min readIn the U.S., donated cadavers fuel medical education and research, but a loosely regulated market allows for-profit "body brokers" to acquire, dissect, and sell human remains with minimal oversight. Unlike live organ donations, parts destined for research face few health screenings or restrictions. This episode features Philip Gayet, a former broker who spent over a decade in the trade, detailing its operations, profits, and pitfalls.
From University Sourcing to Brokering
Philip Gayet entered the cadaver trade in 1993 after a back injury ended his land surveying work. An acquaintance connected him to a Southern California medical school needing bodies for its 250 anatomy students, requiring about 80 cadavers yearly. With few local donors, Gayet networked with other schools like UC Irvine and San Diego, taking referrals from beyond their 50-mile radius limits.
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
What you'll learn
- 1 **[01:07] Lack of Regulation in Body Brokering**
- 2 **[02:04] Episode Intro and Part 1 Recap**
- 3 **[02:58] Philip Gayette Enters the Cadaver Trade**
- 4 **[04:52] Discovering Profitable Body Brokers**
- 5 **[06:49] Launching Own Firm and Sourcing Donors**
- 6 **[08:13] Vague Consent and Crude Dissection**
- 7 **[12:14] Major Buyers and Lucrative Markets**
+ Full timestamped outline available in the app
Show Notes
In the final part of our series, Zachary Crockett talks to a man with a storied — and controversial — career in the body parts business. This episode was originally published on October 29th, 2023.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More from this podcast
The Economics of Everyday Things →